Davidson Kempner Capital Management’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-474,400
Closed -$1.07M 226
2020
Q1
$1.07M Sell
474,400
-50,000
-10% -$96K 0.03% 131
2019
Q4
$996K Buy
+524,400
New +$1.06M 0.02% 136

Davidson Kempner Capital Management's IMVTW Position: Q2 2020 in Review

Davidson Kempner Capital Management sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 474,400 shares — an estimated $1.07M sold.

Davidson Kempner Capital Management first reported a position in IMVTW in Q4 2019 and held it in 2 quarters. The position peaked at $1.07M in Q1 2020. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.

  • Davidson Kempner Capital Management reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 474,400 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $1.07M.
  • Davidson Kempner Capital Management first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q4 2019 and held it in 2 quarters.
  • Davidson Kempner Capital Management's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $1.07M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.